Damon Runyon Funds High-Risk Cancer Studies | GenomeWeb

NEW YORK (GenomeWeb News) – The Damon Runyon Cancer Research Foundation has awarded three grants totaling more than $1.3 million to researchers pursuing high-risk cancer research involving genomics, proteomics, and metabolomics, the foundation said today.

The 2010 Damon Runyon-Rachleff Innovation Awards will give three investigators grants of $450,000, to be spread out over three years at $150,000 per year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.